Equal-WT
WhaleScore 2.0
?
KOHLBERG KRAVIS ROBERTS & COMPANY . L.P.
- https://www.linkedin.com/showcase/kkr-technology/
- HTTP://WWW.KKR.COM
- https://x.com/KKR_Co
- HTTPS://WWW.LINKEDIN.COM/COMPANY/KKR/
- HTTPS://WWW.INSTAGRAM.COM/KKR_CO/
- HTTPS://WWW.LINKEDIN.COM/SHOWCASE/KKR-INDUSTRIALS/
- HTTPS://WWW.YOUTUBE.COM/CHANNEL/UCOU4SYI7BZ0CIDX1Z0NQRCG
- HTTPS://TWITTER.COM/KKR_INDUSTRIALS
- https://kkresg.com/
- http://www.kkrreit.com/
- https://www.linkedin.com/showcase/kkr-real-estate-finance-trust
- http://www.kkrfunds.com
- https://www.youtube.com/@kohlbergkravisroberts
Kohlberg Kravis Roberts & Company . is based out of New York. Kohlberg Kravis Roberts & Company . is a hedge fund with 156 clients and discretionary assets under management (AUM) of $351,954,358,377 (Form ADV from 2025-03-31). Their last reported 13F filing for Q2 2025 included $4,840,715,217 in managed 13F securities
and a top 10 holdings concentration of 94.28%. Kohlberg Kravis Roberts & Company .'s largest holding is BrightSpring Health Services Inc with shares held of 77,096,338. Whalewisdom has at least 85 13F filings
Business Description
Based on the provided documents, KKR provides advisory services related to investments suitable for KKR Funds and Other Clients. These investments are also syndicated to third-party investors through an Affiliated Broker. Dual Personnel provide services to multiple entities, and their compensation is based on factors like profitability, client account performance, and assets under management.
A conflict of interest arises as Dual Personnel may be incentivized to prioritize more profitable affiliated entities. They also work with third-party clients interested in acquiring assets that KKR Funds or Other Clients are also interested in. KKR and Affiliated Brokers have compliance policies to mitigate these conflicts and ensure fair allocation of investment opportunities.
Investment Strategy
Certain KKR Funds and Other Clients are not restricted in terms of the percentage of their capital that can be invested in a particular industry, geographical region or type of investment. Their governing documents often contain a description of the types of investments that other KKR Funds or Other Clients have historically made and/or information about the relevant KKR Funds' or Other Clients' investment expectations.
Many factors contribute to changes in emphasis in the construction of such KKR Funds' or Other Clients' portfolios, including changes in market or economic conditions or regulation as they affect various industries and changes in the political or social situations in particular countries. There can be no assurance that the investment portfolio of any KKR Fund or Other Client will resemble the portfolio of any prior KKR Fund or Other Client.
Owners
- KKR & CO. GP LLC - GENERAL PARTNER OF KOHLBERG KRAVIS ROBERTS & CO. L.P.
- ROBERTS, GEORGE, ROSENBERG - EXECUTIVE CO-CHAIRMAN
- KRAVIS, HENRY, ROBERTS - EXECUTIVE CO-CHAIRMAN
- NUTTALL, SCOTT, CHARLES - CO-CHIEF EXECUTIVE OFFICER
- BAE, JOSEPH, YONG - CO-CHIEF EXECUTIVE OFFICER
- STORK, RYAN, DAVID - CHIEF OPERATING OFFICER
- LEWIN, ROBERT, HOWARD - CHIEF FINANCIAL OFFICER
- KARPATI, BRUCE - GLOBAL CHIEF COMPLIANCE OFFICER & COUNSEL
- HOLMES, DANE, ERIC - CHIEF ADMINISTRATIVE OFFICER
- Sudol, Kathryn, King - CHIEF LEGAL OFFICER Click on the Ownership/Private Fund Data tab for more details.
Other Contact Information
(Subscription Required)
2025-06-30
Top Buys (13F)
| Name | % Change |
|---|---|
| HSIC Henry Schein Inc. | 5.03% |
| CRGY Crescent Energy Co. | 4.61% |
| DEBT-SABR SABRE GLBL INC NOTE (PRN) | 0.35% |
| DEBT-UGI UGI CORP NEW NOTE 5. (PRN) | 0.29% |
| DEBT-SEAG SEAGATE HDD CAYMAN N (PRN) | 0.21% |
2025-06-30
Top Sells (13F)
| Name | % Change |
|---|---|
| BBIO BridgeBio Pharma Inc | 3.21% |
| BV BrightView Holdings | 2.57% |
| DEBT-REAL REALOGY GRP LLC/REAL (PRN) | 2.01% |
| AKAM Akamai Technologies (PRN) | 0.57% |
| BTSG BrightSpring Health | 0.41% |
2025-06-30
13F Holdings Summary
| Name | % of Portfolio |
|---|---|
| BTSG BrightSpring Health | 37.57% |
| HSIC Henry Schein Inc. | 23.62% |
| BBIO BridgeBio Pharma Inc | 11.83% |
| BV BrightView Holdings | 7.08% |
| CRGY Crescent Energy Co. | 4.75% |
2025-06-30
13F Activity
| Market Value | $4.84b, Prior: $4.43b |
| Inflows (Outflows) as % of Total MV | (-8.8215)% |
| New Purchases | 17 stocks |
| Added To | 17 stocks |
| Sold out of | 16 stocks |
| Reduced holdings in | 12 stocks |
| Top 10 Holdings % | 94.28% |
| Turnover %[1] | 35.87% |
| Turnover Alt %[2] | 12.21% |
| Time Held Top 20 | 8.6 quarters |
| Time Held Top 10 | 10.8 quarters |
| Time Held All | 5.87 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2025-06-30
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data
2025-06-30
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2025-06-30